Literature DB >> 2785561

IL-2 induces expression of serine protease enzymes and genes in natural killer and nonspecific T killer cells.

C L Manyak1, G P Norton, C G Lobe, R C Bleackley, H K Gershenfeld, I L Weissman, V Kumar, N H Sigal, G C Koo.   

Abstract

The expression of serine protease genes was examined in murine NK cells that were purified by panning spleen cells with PMA. Although unstimulated NK cells were cytolytic, they were found not to express the C11 (chymotrypsin-like) mRNA. Culturing these cells in IL-2 (500 to 800 U/ml) for 5 to 7 days induced both the lytic activities and the protease enzymes by 20- to 30-fold. Concomitant to these activation events, the total steady state mRNA of both C11 and HF (trypsin-like) genes were also elevated. The activation of lysis, serine protease enzymes, and C11 and HF mRNA all peaked around day 5 in culture and was dose dependent. In order to exclude the possibility that PMA synergizes with IL-2 in this system, spleen cells from SCID mice, which contained mainly NK cells, were cultured under the same conditions (800 U/ml IL-2, with or without PMA) and PMA did not appear to enhance the expression of these mRNA. Similarly, IL-2 also induced the lytic activities, enzyme levels, and mRNA in the non-Ag-specific T killer cells isolated from spleens of normal mice. Lytic activity of T killer cells was not as high as the NK cells, however, the addition of PHA into the lytic assay resulted in enhanced lysis comparable to that of NK cells. These results showed that lytic activity increased along with protease enzyme levels and mRNA expression in both NK and resting T cells. Therefore, elevated levels of the protease enzymes could be one mechanism involved in optimal lytic activity of IL-2-induced lymphokine activated killer cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785561

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells.

Authors:  Anita Parmigiani; Maria F Pallin; Helena Schmidtmayerova; Mathias G Lichtenheld; Savita Pahwa
Journal:  Hum Immunol       Date:  2010-10-25       Impact factor: 2.850

2.  Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists.

Authors:  S J Won; Y C Chuang; W T Huang; H S Liu; M T Lin
Journal:  Experientia       Date:  1995-04-15

3.  Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.

Authors:  J Y Blay; D Branellec; E Robinet; B Dugas; F Gay; S Chouaïb
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.

Authors:  Joel D Pearson; Jason K H Lee; Julinor T C Bacani; Raymond Lai; Robert J Ingham
Journal:  Int J Clin Exp Pathol       Date:  2011-01-30

5.  Transgenic mice carrying the diphtheria toxin A chain gene under the control of the granzyme A promoter: expected depletion of cytotoxic cells and unexpected depletion of CD8 T cells.

Authors:  H L Aguila; R J Hershberger; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  Increased expression of perforin and granzyme B genes in patients with metastatic melanoma treated with recombinant interleukin-2.

Authors:  M B Leger-Ravet; C Mathiot; A Portier; M Brandely; P Galanaud; W H Fridman; D Emilie
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

7.  Heterogeneity of murine adherent interleukin-2-activated killer cells. Differential effect of prostaglandin E2 and forskolin.

Authors:  D Vaillier; R Daculsi; N Gualde
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

8.  Molecular cloning of gp42, a cell-surface molecule that is selectively induced on rat natural killer cells by interleukin 2: glycolipid membrane anchoring and capacity for transmembrane signaling.

Authors:  W E Seaman; E C Niemi; M R Stark; R D Goldfien; A S Pollock; J B Imboden
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.